![Sandesh Seth](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sandesh Seth
Directeur Général chez
ACTINIUM PHARMACEUTICALS, INC.
Fortune : 206 619 $ au 30/09/2026
Profil
Mr. Sandesh Seth is a Chairman & Chief Executive Officer at Actinium Pharmaceuticals, Inc. and a Managing Partner at Jamess Capital Group LLC.
Mr. Seth was previously employed as a Lead Director by Camp Nine, Inc., a Lead Director by Relmada Therapeutics, Inc. /Old/, a Chairman by Relmada Therapeutics, Inc., and a Head-Healthcare Investment Banking by Laidlaw & Co. (UK) Ltd. He also served on the board at Cactus Ventures, Inc. and Actinium Pharmaceuticals, Inc. /Old/.
He received his undergraduate degree from the University of Mumbai and an MBA from New York University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 02/09/2026 | 184 481 ( 0,59 % ) | 206 619 $ | 30/09/2026 |
Postes actifs de Sandesh Seth
| Sociétés | Poste | Début |
|---|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Directeur Général | 09/06/2017 |
Jamess Capital Group LLC | Corporate Officer/Principal | - |
Anciens postes connus de Sandesh Seth
| Sociétés | Poste | Fin |
|---|---|---|
| RELMADA THERAPEUTICS, INC. | Président | 06/06/2017 |
Laidlaw & Co. (UK) Ltd.
 Laidlaw & Co. (UK) Ltd. Investment Banks/BrokersFinance Provides investment advice | Corporate Officer/Principal | 01/07/2015 |
Actinium Pharmaceuticals, Inc. /Old/
 Actinium Pharmaceuticals, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Develops and commercializes alpha particle immunotherapeutics | Directeur/Membre du Conseil | 18/04/2013 |
Cactus Ventures, Inc.
 Cactus Ventures, Inc. Financial ConglomeratesFinance Operates as a blank check company | Directeur/Membre du Conseil | 18/04/2013 |
Camp Nine, Inc.
 Camp Nine, Inc. Pharmaceuticals: GenericHealth Technology Operates as a clinical stage biopharmaceutical company | Directeur/Membre du Conseil | - |
Formation de Sandesh Seth
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
57
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Actinium Pharmaceuticals, Inc. /Old/
Actinium Pharmaceuticals, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Develops and commercializes alpha particle immunotherapeutics | Commercial Services |
Cactus Ventures, Inc.
Cactus Ventures, Inc. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Camp Nine, Inc.
Camp Nine, Inc. Pharmaceuticals: GenericHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
New York University
 New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Mumbai
 University of Mumbai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Laidlaw & Co. (UK) Ltd.
Laidlaw & Co. (UK) Ltd. Investment Banks/BrokersFinance Provides investment advice | Finance |
Relmada Therapeutics, Inc. /Old/
 Relmada Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs for the treatment of acute and chronic pains | Health Technology |
Actinium Pharmaceuticals, Inc.
 Actinium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company developing targeted payload immunotherapeutic for the treatment of advanced cancers | Health Technology |
Jamess Capital Group LLC | |
Relmada Therapeutics, Inc.
 Relmada Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drug products for the treatment of depression and other central nervous system diseases | Health Technology |
